当前位置:首页 - 行情中心 - 双鹭药业(002038) - 财务分析 - 资产负债表

双鹭药业

(002038)

  

流通市值:62.10亿  总市值:74.89亿
流通股本:8.52亿   总股本:10.27亿

资产负债表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
流动资产:
  货币资金346,304,398.88328,747,917.07411,958,243.66433,638,552
  交易性金融资产540,639,787.88456,087,288.99480,855,467.52487,549,337.99
  应收票据及应收账款85,985,897.64100,483,666.91102,965,551.13114,670,019.55
        应收账款85,985,897.64100,483,666.91102,965,551.13114,670,019.55
  应收款项融资--2,822,933.53771,658.01
  预付款项116,292,983.1153,479,508.72121,155,659.03114,175,239.49
  其他应收款合计15,137,646.6715,223,716.5415,647,268.0622,216,856.37
  存货415,420,300.1403,254,298.06246,333,789.57236,842,314.19
  一年内到期的非流动资产260,864,500328,251,388.9325,713,888.89-
  其他流动资产782,097,512.2776,260,991.85781,386,164.26794,860,395.27
  流动资产合计2,562,743,026.472,561,788,777.042,488,838,965.652,204,724,372.87
非流动资产:
  长期股权投资956,086,892.46954,827,731.35951,933,309.68953,926,287.88
  其他非流动金融资产279,813,440.57279,837,831.19279,545,423.72275,764,986.92
  投资性房地产12,723,542.6412,949,974.3913,176,406.1413,402,837.89
  固定资产404,786,780.85413,163,165.64419,321,790.24422,275,232.36
  在建工程122,149,772.9999,844,535.0994,922,038.3983,292,668.13
  无形资产695,530,411.68713,137,683.23678,581,445.8642,984,295.95
  开发支出486,076,956.2479,761,974.97517,283,516.42496,091,641.11
  长期待摊费用1,579,230.821,718,700.91,718,700.91,858,170.98
  递延所得税资产64,373,928.8465,836,193.369,522,944.42-
  其他非流动资产432,017,039.32481,836,271.96464,174,777.38817,312,944.18
  非流动资产合计3,455,137,996.373,502,914,062.023,490,180,353.093,706,909,065.4
  资产总计6,017,881,022.846,064,702,839.065,979,019,318.745,911,633,438.27
流动负债:
  应付票据及应付账款49,045,557.32139,278,548.4122,285,265.9298,871,063.9
  其中:应付票据8,474,343.710,538,577.61,260,0001,260,000
        应付账款40,571,213.62128,739,970.8121,025,265.9297,611,063.9
  预收款项847,744.5110,822.825,830.715,987,770.68
  合同负债75,567,317.95106,387,042.170,506,152.6211,853,735.2
  应付职工薪酬35,488,979.9437,100,791.9142,948,812.3632,569,394.75
  应交税费2,378,182.412,573,778.483,486,281.893,981,896.14
  其他应付款合计34,177,680.3943,754,567.1147,598,720.4639,137,945.58
  其他流动负债2,806,867.854,789,340.122,554,056.362,157,419.51
  流动负债合计200,312,330.36333,994,890.92289,405,120.31204,559,225.76
非流动负债:
  递延收益41,166,185.2341,166,185.2343,996,123.144,170,123.1
  递延所得税负债75,131,398.8163,276,340.264,969,835.9524,714,961.3
  非流动负债合计116,297,584.04104,442,525.43108,965,959.0568,885,084.4
  负债合计316,609,914.4438,437,416.35398,371,079.36273,444,310.16
所有者权益(或股东权益):
  实收资本(或股本)1,027,350,0001,027,350,0001,027,350,0001,027,350,000
  资本公积49,615,655.8749,615,655.8749,615,655.8749,615,655.87
  其他综合收益13,474,826.2513,474,826.2513,474,826.2513,474,826.25
  盈余公积632,410,430.74632,410,430.74632,410,430.74632,410,430.74
  未分配利润3,970,645,232.243,895,565,435.163,849,597,029.543,906,927,106.17
  归属于母公司股东权益合计5,693,496,145.15,618,416,348.025,572,447,942.45,629,778,019.03
  少数股东权益7,774,963.347,849,074.698,200,296.988,411,109.08
  股东权益合计5,701,271,108.445,626,265,422.715,580,648,239.385,638,189,128.11
  负债和股东权益合计6,017,881,022.846,064,702,839.065,979,019,318.745,911,633,438.27
公告日期2025-08-262025-04-222025-04-222024-10-26
审计意见(境内)标准无保留意见
TOP↑